Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke
Intravenous (IV) tissue plasminogen activator (tPA) is the only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke. Post tPA patients are typically monitored in an intensive care unit (ICU) for at least 24 hours. However, rigorous evidence to support this practice is lac...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2014
|
| 在線閱讀: | https://doi.org/10.1371/journal.pone.0088652 https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0088652&type=printable |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|